Cent. Carolina Surgical Eye Assocs., P.A. v. Matthews

2022 NCBC 14
CourtNorth Carolina Business Court
DecidedMarch 16, 2022
Docket21-CVS-3201
StatusPublished

This text of 2022 NCBC 14 (Cent. Carolina Surgical Eye Assocs., P.A. v. Matthews) is published on Counsel Stack Legal Research, covering North Carolina Business Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cent. Carolina Surgical Eye Assocs., P.A. v. Matthews, 2022 NCBC 14 (N.C. Super. Ct. 2022).

Opinion

Cent. Carolina Surgical Eye Assocs., P.A. v. Matthews, 2022 NCBC 14.

STATE OF NORTH CAROLINA IN THE GENERAL COURT OF JUSTICE SUPERIOR COURT DIVISION WAKE COUNTY 21 CVS 3201

CENTRAL CAROLINA SURGICAL EYE ASSOCIATES, P.A. by and through GERALD JEUTTER, Receiver,

Plaintiff, ORDER AND OPINION ON RULE 12(c) CROSS-MOTIONS FOR v. JUDGMENT ON THE PLEADINGS JOHN D. MATTHEWS, M.D.,

Defendant.

1. THIS MATTER is before the Court upon Defendant John D. Matthews,

M.D.’s (“Matthews”) Motion for Judgment on the Pleadings Pursuant to Rule 12(c) of

the North Carolina Rules of Civil Procedure (“Rule(s)”) (“Matthews’ Motion”), (ECF

No. 31), 1 and Plaintiff Central Carolina Surgical Eye Associates, P.A.’s (“CCSEA”),

Rule 12(c) Motion for Judgment on the Pleadings (“CCSEA’s Motion;” together, the

“Motions”), (ECF No. 29).

2. Matthews contends in his Motion that CCSEA has asserted claims that

expand or add to the claims CCSEA previously asserted against Matthews in a prior,

now voluntarily dismissed action and that those claims should be dismissed in part

or in full because they are time-barred or because they fail to otherwise state a claim. 2

1 Unless otherwise specified, court filings cited herein have been filed in this action (21 CVS

3201). The case number for cited case filings from other actions will be provided when they are cited for the first time.

2 (Def. Matthews’ Mot. J. on Pleadings Pursuant to Rule 12(c) ¶ 15 [hereinafter “Def.’s Mot.”],

ECF No. 31.) 3. CCSEA asserts in its Motion that four of Matthews’ counterclaims, each of

which seeks recovery of sums Matthews alleges he is owed for unpaid compensation

and distributions as an employee and shareholder of CCSEA, are fatally deficient as

pleaded and should be dismissed as a matter of law. 3

4. After reviewing the Motions, the related briefing, the arguments of counsel

at the hearing on the Motions, and other appropriate matters of record, the Court

GRANTS in part and DENIES in part each Motion for the reasons set forth below.

Law Offices of Richard M. Greene, by Richard M. Greene, for Plaintiff Central Carolina Surgical Eye Associates, P.A.

Oak City Law LLP, by Robert E. Fields, III, for Gerald A. Jeutter, Jr., Receiver for Central Carolina Surgical Eye Associates, P.A.

Pinto Coates Kyre & Bowers, PLLC, by Lyn K. Broom, and Teague Rotenstreich Stanaland Fox & Holt PLLC, by Steven B. Fox and Mallory G. Horn, for Defendant John D. Matthews, M.D.

Bledsoe, Chief Judge.

I.

FACTUAL AND PROCEDURAL BACKGROUND

A. Factual Background

5. CCSEA was an ophthalmological medical practice in Greensboro, North

Carolina that was formed in 1992 when Richard Epes, M.D. (“Epes”) and Matthews

sold their interests in a predecessor entity known as Central Carolina Surgical Eye

Associates, P.A. (“Old CCSEA”) and formed a new medical practice using the same

3 (Pl.’s Rule 12(c) Mot. J. on Pleadings [hereinafter “Pl.’s Mot.”], ECF No. 29.) name. 4 Epes and Matthews acquired all of the stock in the new CCSEA, with Epes

holding 75% of the stock and Matthews holding 25%. 5

6. CCSEA alleges that Matthews entered an Employment Agreement with

CCSEA in 1992 to provide ophthalmological services as a part of the sale of Old

CCSEA and that Matthews has been a director and officer of CCSEA ever since.

(2021 Compl. ¶¶ 5–8). The initial term of the Employment Agreement was for five

years, and the Agreement automatically renewed for subsequent five-year terms

unless Matthews provided notice of his intent to terminate at least one year prior to

the end of any five-year term. (2021 Compl. Ex. A at 2.) The Agreement contained

non-competition and non-solicitation covenants purporting to restrict Matthews’

ability to compete against CCSEA and solicit its patients and employees.

7. The parties acknowledge that Matthews and six other CCSEA employees

left their employment with CCSEA on 19 July 2012 and within days of their

departure began providing ophthalmological services under the trade name Triad

4 (Compl. ¶¶ 4–5 [hereinafter “2021 Compl.”], ECF No. 4; 2021 Compl. Ex. A, ECF No. 4.1.)

5 (2021 Compl. ¶¶ 4–5; Def.’s Answer, Mot. Dismiss and Countercl. ¶¶ 4–5 [hereinafter “2021

Answer”], ECF No. 14.) Matthews has filed four separate answers and counterclaims in the lawsuits between these two parties: (i) a 20 August 2015 Motion to Dismiss, Answer, and Counterclaims, (“2015 Answer and Countercl.,” ECF No. 10.3 (15 CVS 7266)); (ii) an 8 January 2016 Amended Motion to Dismiss, Answer and Counterclaims for Set-off/Offset and Constructive Trust, (“2015 Am. Answer and Countercl.,” ECF No. 289 (15 CVS 1648)); (iii) a 10 June 2021 Answer, Motion to Dismiss and Counterclaims, (“2021 Answer and Countercl.,” ECF No. 14); and (iv) a 13 August 2021 Amended Answer, Motions to Dismiss and Counterclaims, (“2021 Am. Answer and Countercl.,” ECF No. 25), which amended the 2021 counterclaims but not the 2021 answer. The answer and counterclaim paragraphs of each filing are separately numbered, so, to avoid ambiguity, the answer portions will be cited as “2015 Answer,” “2015 Am. Answer,” and “2021 Answer,” and the counterclaim portions will be cited as “2015 Countercl.,” “2015 Am. Countercl.,” “2021 Countercl.,” and “2021 Am. Countercl.” Retina and Diabetic Eye Center (“Triad Retina”) at a fully equipped medical facility

located within five miles of CCSEA. (2021 Compl. ¶¶ 14, 16; 2021 Answer ¶¶ 14, 16.)

According to CCSEA, the Employment Agreement had automatically renewed for a

five-year term through 30 June 2017 and was in full force and effect at the time

Matthews and his departing colleagues terminated their employment with CCSEA.

(2021 Compl. ¶ 13.)

8. CCSEA alleges that soon thereafter patients began calling CCSEA to report

that Triad Retina had been calling them on behalf of Matthews and soliciting them

to become new patients of Triad Retina. (2021 Compl. ¶ 46.) CCSEA further alleges

that Matthews used confidential patient information to solicit patients away from

CCSEA for Matthews’ “financial benefit,” ultimately causing “more than 1,400

patients” to leave CCSEA’s practice for Triad Retina and causing CCSEA to “suffer

significant damages and loss of patient revenue[.]” (2021 Compl. ¶¶ 21, 33–34, 40.)

9. For his part, Matthews denies the enforceability of the Employment

Agreement on various grounds, contends that the Agreement was terminated no later

than 2007, rendering him an at-will employee at liberty to leave CCSEA’s

employment without further obligation thereunder, (2021 Countercl. ¶¶ 14, 23; see,

e.g., 2021 Answer ¶ 14), and asserts that he was never an officer or a director of

CCSEA, alleging that Epes “effectively shut him out of those roles[,]” (2021 Countercl.

¶ 11; 2021 Answer ¶¶ 27–37, 43–55). He also asserts counterclaims, alleging that

during his employment, CCSEA continuously undercompensated him, 6 failed to

6 (2015 Am. Countercl. ¶¶ 16(a)–(b), (d)–(f), (l)–(p), (v), 20–29, 46–51; 2021 Countercl. ¶¶ 15(a)–(b), (d)–(f), (l)–(p), (v), 19–20, 27–28.) provide him with adequate equipment and facilities, 7 and failed to pay him required

distributions. 8

10. CCSEA is no longer operating and is in receivership. Old Battleground

Props. v. Cent. Carolina Surgical Eye Assocs., P.A., 2015 NCBC LEXIS 19, *24 (N.C.

Super. Ct. Feb. 25, 2015).

B. Procedural Background 9

11. CCSEA’s receiver, Gerald Jeutter, has filed two actions against Matthews

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Spence v. Spaulding and Perkins, Ltd.
347 S.E.2d 864 (Court of Appeals of North Carolina, 1986)
Potter v. Hilemn Laboratories, Inc.
564 S.E.2d 259 (Court of Appeals of North Carolina, 2002)
Ragsdale v. Kennedy
209 S.E.2d 494 (Supreme Court of North Carolina, 1974)
Booher v. Frue
394 S.E.2d 816 (Court of Appeals of North Carolina, 1990)
Housing, Inc. v. Weaver
246 S.E.2d 219 (Court of Appeals of North Carolina, 1978)
Losing v. Food Lion, L.L.C.
648 S.E.2d 261 (Court of Appeals of North Carolina, 2007)
Holley v. Hercules, Inc.
359 S.E.2d 47 (Court of Appeals of North Carolina, 1987)
Stutts v. Duke Power Co.
266 S.E.2d 861 (Court of Appeals of North Carolina, 1980)
Brisson v. Kathy A. Santoriello, M.D., P.A.
528 S.E.2d 568 (Supreme Court of North Carolina, 2000)
Murdock v. Chatham County
679 S.E.2d 850 (Court of Appeals of North Carolina, 2009)
White v. Thompson
691 S.E.2d 676 (Supreme Court of North Carolina, 2010)
Flexolite Electrical, Ltd. v. Gilliam
284 S.E.2d 523 (Court of Appeals of North Carolina, 1981)
Housecalls Home Health Care, Inc. v. State
682 S.E.2d 741 (Court of Appeals of North Carolina, 2009)
Steele v. Locke Cotton Mills Co.
58 S.E.2d 620 (Supreme Court of North Carolina, 1950)
Stanford v. Owens
332 S.E.2d 730 (Court of Appeals of North Carolina, 1985)
Van Every v. Van Every
144 S.E.2d 603 (Supreme Court of North Carolina, 1965)
Toomer v. Branch Banking and Trust Co.
614 S.E.2d 328 (Court of Appeals of North Carolina, 2005)
Ken-Lu Enterprises, Inc. v. Neal
223 S.E.2d 831 (Court of Appeals of North Carolina, 1976)
Brannock v. Brannock
523 S.E.2d 110 (Court of Appeals of North Carolina, 1999)
Haynie v. Cobb
698 S.E.2d 194 (Court of Appeals of North Carolina, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
2022 NCBC 14, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cent-carolina-surgical-eye-assocs-pa-v-matthews-ncbizct-2022.